Lebanon vs Philippines: Women's share of population ages 15+ living with HIV
Lebanon
8.9%
in 2024
Philippines
7.1%
in 2024
Lebanon rank
168th
Philippines rank
171st
Women's share of population ages 15+ living with HIV over time
- Lebanon
- Philippines
How they compare
Lebanon currently reports 8.9% against 7.1% in Philippines, a difference of 1.8%.
That makes Lebanon's figure about 1.3 times Philippines's.
Across all 35 years both countries report, Lebanon has been ahead every year.
Lebanon ranks 168th and Philippines ranks 171st of 172 countries.
Lebanon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Lebanon | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 41.1% | 30.5% | 10.6% | Lebanon |
| 2000s | 26.0% | 10.3% | 15.7% | Lebanon |
| 2010s | 15.3% | 6.7% | 8.7% | Lebanon |
| 2020s | 10.0% | 6.9% | 3.1% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Lebanon or Philippines?
- Lebanon, at 8.9% against 7.1% in Philippines as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Lebanon and Philippines?
- 1.8%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Philippines?
- 35 years are reported by both, from 1990 to 2024.
- How do Lebanon and Philippines rank globally for women's share of population ages 15+ living with hiv?
- Lebanon ranks 168th and Philippines ranks 171st of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.